Neuroene Therapeutics

We are thrilled to announce that our compound, NT102, has received FDA Rare Pediatric Disease Designation! This designation recognizes our commitment to addressing critical unmet needs for children with Dravet Syndrome. This milestone brings us one step closer to making a difference in the lives of patients and their families. #dravetsyndrome #epilepsy #mitochondria #PediatricHealth #RareDisease

A full house at the Michael J. Fox Foundation 2024 Parkinson's Disease Therapeutics Conference in NYC! Looking forward to meeting everyone and learning about the latest in the pipeline. #parkinsonsdisease #mitochondria #mjff

We're at the BioHealth Capital Region Forum this week at the US Pharmacopeia. Beautiful space, great speakers (including two Governors, Montgomery County executive, major Pharma, university leaders and many others)! We'll be pitching on Thursday for the Investor Conference portion of this meeting. See you there! #epilepsy #parkinsonsdisease #raredisease #mitochondria

Sherine Chan, co-founder and CEO of Neuroene Therapeutics, shares how Neuroene's small molecule compounds support mitochondrial health to target neurological diseases like epilepsy. Follow along this week as we share more stories of #SmallMoleculesBigVoices from scientists, patient advocates, and policymakers.

Fantastic news for Neuroene Therapeutics! We are excited to announce that Neuroene is the Emerging Company Winner of Biotechnology Innovation Organization's Start-Up Stadium Pitch Contest at the 2024 BIO International Convention! Thank you to the judges and to all who attended our pitch - your enthusiasm for our mitochondrial therapeutics for epilepsy, Parkinson's disease and mitochondrial diseases gives us validation and further motivation to get to the clinic as fast as possible - the patients are waiting! Thanks to J.P. Carroll for a great write-up! https://lnkd.in/ecmec9Vf #BIO2024 #BIO #epilepsy #parkinsonsdisease #parkinsons #dravetsyndrome #mitochondria #mitochondrialdisease #neuroene

What an amazing #BIO2024! Grateful for Neuroene Therapeutics' QuickFire Challenge award from #BLUEKNIGHT and to BIO for organizing fantastic events. Had productive partnership meetings at the business forum and after-hours receptions. Startup Stadium was a blast to pitch at, and thank you to all who attended to hear about our work and for those who connected afterward. It was a pleasure meeting new friends and reconnecting with old ones. Special thanks to Natalie J. Galant, PhD for the arm pose tutorial :) #epilepsy #parkinsonsdisease #mitochondria

We are thrilled to be announced as one of the awardees for the hashtag #BLUEKNIGHT #QuickFireChallenge. Inspired to continue innovating for a better and safer future. #neuroene #epiloid #epilepsy #parkinsonsdisease #mitochondria